Naval Health Research Center, 140 Sylvester Road, San Diego, CA 92106-3521.
Leidos, Inc., 140 Sylvester Road, San Diego, CA 92106-3521.
Mil Med. 2020 Aug 14;185(7-8):e1091-e1100. doi: 10.1093/milmed/usaa038.
Limited research has analyzed the full range of outpatient medication prescription activity following serious combat injury. The objectives of this study were to describe (1) outpatient medication prescriptions and refills during the first 12 months after serious combat injury, (2) longitudinal changes in medication prescriptions during the first-year postinjury, and (3) patient characteristics associated with outpatient prescriptions.
This was a retrospective analysis of existing health and pharmacy data for a random sample of U.S. service members who sustained serious combat injuries in the Iraq and Afghanistan conflicts, 2010-2013 (n = 381). Serious injury was defined by an Injury Severity Score (ISS) of 9 or greater. These patients typically participate in military rehabilitation programs (eg, amputation care) where prescription medications are essential. Data sources were the Expeditionary Medical Encounter Database for injury-specific data, the Pharmacy Data Transaction Service for outpatient medication prescriptions and refills, and the Military Health System Data Repository for diagnostic codes of pain and psychological disorders. Military trauma nurses reviewed casualty records to identify types of injuries. Using the American Hospital Formulary Service Pharmacologic-Therapeutic Classification system, clinicians identified 13 categories of prescription medications (eg, opioid, psychotherapeutic, immunologic) for analysis. Multivariable negative binomial and logistic regression analyses evaluated significant associations between independent variables (eg, blast injury, traumatic brain injury [TBI], ISS, limb amputation, diagnoses of chronic pain, or psychological disorders) and prescription measures (ie, number or category of medication prescriptions). We also describe longitudinal changes in prescription activity postinjury across consecutive quarterly intervals (91 days) during the first-year postinjury.
During the first-year postinjury, patients averaged 61 outpatient prescriptions, including all initial prescriptions and refills. They averaged eight different categories of medications, primarily opioid, immunologic, gastrointestinal/genitourinary, central nervous system (CNS), nonopioid analgesic, and psychotherapeutic medications (representing 82% of prescriptions) during the first year. Prescription activity generally declined across quarters. There was still substantial prescription activity during the fourth quarter, as 79% of patients had at least one prescription. From 39 to 49% of patients had fourth-quarter prescriptions for opioid, CNS, or psychotherapeutic medications. Longitudinally, we found that 24-34% of patients had an opioid, CNS, or psychotherapeutic prescription during each of the final three quarters. In multivariable analysis, ISS, limb amputation (particularly bilateral amputation), and diagnoses of chronic pain and post-traumatic stress disorder (PTSD) were associated with significantly higher counts of individual and multiple medication prescriptions. TBI was associated with significantly lower numbers of prescriptions for certain medications.
This is one of the first studies to provide a systematic analysis of outpatient medication prescriptions following serious combat injury. The results indicate substantial prescription activity from multiple medication categories throughout the first-year postinjury. Diagnoses of chronic pain, PTSD, and limb amputation and ISS were associated with significantly higher counts of prescriptions overall and more prescription medication categories. This study provides initial evidence to better understand medication prescription activity following serious combat injury. The results inform future research on medication prescription practices and planning for rehabilitation.
有限的研究分析了严重战斗伤害后门诊药物处方活动的全部范围。本研究的目的是描述:(1) 严重战斗伤害后 12 个月内的门诊药物处方和续方;(2) 受伤后第一年药物处方的纵向变化;(3) 与门诊处方相关的患者特征。
这是对 2010-2013 年在伊拉克和阿富汗冲突中遭受严重战斗伤害的美国军人随机样本的现有健康和药房数据进行的回顾性分析(n=381)。严重伤害的定义是损伤严重程度评分(ISS)为 9 或更高。这些患者通常参加军事康复计划(例如,截肢护理),其中处方药物是必不可少的。数据来源是伤害特定数据的远征医疗遭遇数据库、门诊药物处方和续方的药房数据事务服务,以及诊断疼痛和心理障碍的军事健康系统数据存储库。军事创伤护士审查伤员记录以确定受伤类型。临床医生使用美国医院配方服务药物治疗分类系统,确定了 13 类处方药物(例如,阿片类、精神治疗、免疫类)进行分析。多变量负二项和逻辑回归分析评估了独立变量(例如,爆炸伤、创伤性脑损伤[TBI]、ISS、肢体截肢、慢性疼痛或心理障碍的诊断)与处方措施(即,药物处方的数量或类别)之间的显著关联。我们还描述了受伤后第一年连续四个季度(91 天)的处方活动纵向变化。
在受伤后的第一年,患者平均有 61 张门诊处方,包括所有初始处方和续方。他们在第一年中平均使用了 8 种不同类别的药物,主要是阿片类、免疫类、胃肠道/泌尿生殖类、中枢神经系统(CNS)、非阿片类镇痛药和精神治疗类药物(占处方的 82%)。处方活动总体呈下降趋势。第四季度仍有大量的处方,因为 79%的患者至少有一张处方。79%至 49%的患者在第四季度有阿片类、CNS 或精神治疗类药物的处方。纵向来看,我们发现 24%至 34%的患者在最后三个季度的每个季度都有阿片类、CNS 或精神治疗类药物的处方。多变量分析显示,ISS、肢体截肢(特别是双侧截肢)以及慢性疼痛和创伤后应激障碍(PTSD)的诊断与个体和多种药物处方的数量显著增加相关。TBI 与某些药物的处方数量显著减少有关。
这是第一项对严重战斗伤害后门诊药物处方进行系统分析的研究之一。结果表明,在受伤后的第一年中,从多个药物类别中开具了大量处方。慢性疼痛、PTSD 和肢体截肢以及 ISS 的诊断与总体处方数量和更多的处方药物类别显著相关。本研究为更好地了解严重战斗伤害后的药物处方活动提供了初步证据。结果为药物处方实践和康复规划提供了信息。